Drug Type Small molecule drug |
Synonyms E3A, Estradiol 3-acetate, Estradiol acetate (USAN) + [5] |
Target |
Mechanism ERs agonists(Estrogen receptors agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (20 Mar 2003), |
Regulation- |
Molecular FormulaC20H26O3 |
InChIKeyFHXBMXJMKMWVRG-SLHNCBLASA-N |
CAS Registry4245-41-4 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D04061 | Estradiol Acetate |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Vasomotor symptom | US | 20 Mar 2003 | |
Vulvovaginal atrophy | US | 20 Mar 2003 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hot Flashes | Phase 3 | US | 01 Feb 2003 | |
Urogenital Diseases | Phase 3 | US | 01 Feb 2003 |
Not Applicable | 71 | estrogen+Depo-Provera (Femring) | qlqigcsqhb(dlsucbhpcc) = onpddnrybq rjzejhsssi (zatqbgasin, bhqqroluhx - opzfbjgzpj) View more | - | 21 Jul 2011 | ||
(Depot Medroxyprogesterone Acetate (DMPA) Alone) | qlqigcsqhb(dlsucbhpcc) = gwdgqyixzk rjzejhsssi (zatqbgasin, vhhumywmzk - ndrrhvvzsm) View more | ||||||
Phase 3 | 249 | (Estradiol Acetate (E3A)) | vgzatpbryg(fakplhnknt) = wvmlsvpsdd tjflwsbxap (qazhidveyg, ahjbhhqpkx - jjwmjhfpda) View more | - | 08 Apr 2011 | ||
(Estradiol) | vgzatpbryg(fakplhnknt) = dfonglioqz tjflwsbxap (qazhidveyg, hpomimpjiq - xbmxrlenmw) View more |